CAZ-AVI treated patients with cIAI as effectively as meropenem CAZ-AVI also treated cIAI patients infected with ceftazidime-resistant bacteria as...
Read moreFOR EU MEDIA ONLY: NOT FOR SWISS/U.S. MEDIA EMA accepts accelerated review for orphan therapy in hard-to-treat thyroid cancer Eisai...
Read moreAbbott and the United States Department of Defense today announced a collaboration with the intent to develop portable blood tests...
Read moreThe U.S. Food and Drug Administration (FDA) today granted tentative approval for Basaglar™ (insulin glargine injection), which is indicated to...
Read moreCoherus BioSciences, Inc. ("Coherus") today announced that CHS-1420, its proposed biosimilar of adalimumab (Humira®), met the primary endpoint in a...
Read moreAustralia-based regenerative medicine company Mesoblast has signed an agreement with the US National Institutes of Health's (NIH) National Heart, Lung...
Read moreFabtech has launched three new products: the Sampling Booth, Mist Shower, and Discharge Collection with flame-proof execution. The Sampling Booth...
Read moreFirst new treatment option for women in Europe in more than 15 years for most difficult to treat form of...
Read moreBristol-Myers Squibb and Allied Minds have formed a new jointly owned enterprise, Allied-Bristol Life Sciences, aimed at advancing discoveries of...
Read moreWith monumental health reform coming into effect, the pharmaceutical industry is learning to speak a second language. Clinical efficacy is...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
